Skip to main content
Log in

Are monoclonal antibodies cost effective in mCRC?

  • Review
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Lange A, et al. A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer. European Journal of Cancer : 4 Sep 2013. Available from: URL: http://dx.doi.org/10.1016/j.ejca.2013.08.008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Are monoclonal antibodies cost effective in mCRC?. PharmacoEcon Outcomes News 688, 7 (2013). https://doi.org/10.1007/s40274-013-0757-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0757-z

Navigation